Evidence map›Paper›PMID 36445154›Full record

ArticlemSphere2022

Identification of an α-(1

Chihiro Kadooka, Daisuke Hira, Yutaka Tanaka, Ken Miyazawa, Masaaki Bise, Shogo Takatsuka, Takuji Oka

Open access · goldAbstract read
In one paragraph

Article in mSphere, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Conidium Specific Polysaccharides inJournal of fungi (Basel, Switzerland) · 2023
    Article
  7. Identification of Compounds PreventingInternational journal of molecular sciences · 2023
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Chihiro KadookaDepartment of Biotechnology and Life Sciences, Sojo Universitygrid.412662.5, Kumamoto, Japan.
Daisuke HiraDepartment of Biotechnology and Life Sciences, Sojo Universitygrid.412662.5, Kumamoto, Japan.
Yutaka TanakaDivision of Infection and Host Defense, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Ken MiyazawaDepartment of Fungal Infection, National Institute of Infectious Diseasesgrid.410795.e, Tokyo, Japan.ORCID 0000-0001-9211-1020
Masaaki BiseDepartment of Biotechnology and Life Sciences, Sojo Universitygrid.412662.5, Kumamoto, Japan.
Shogo TakatsukaDepartment of Fungal Infection, National Institute of Infectious Diseasesgrid.410795.e, Tokyo, Japan.
Takuji OkaDepartment of Biotechnology and Life Sciences, Sojo Universitygrid.412662.5, Kumamoto, Japan.ORCID 0000-0002-5691-654X
Sojo University · JPNational Institute of Infectious Diseases · JPTohoku Medical and Pharmaceutical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fungal-type galactomannan, a cell wall component of Aspergillus fumigatus, is composed of α-(1→2)-/α-(1→6)-linked mannan and β-(1→5)-/β-(1→6)-linked galactofuran side chains. Recently, CmsA and CmsB were identified as the α-(1→2)-mannosyltransferases involved in the biosynthesis of the α-core-mannan. However, the α-(1→6)-mannosyltransferase involved in the biosynthesis of the α-core-mannan has not been identified yet. In this study, we analyzed 9 putative α-(1→6)-mannosyltransferase gene disruption strains of A. fumigatus. The Δ

Indexed as

Aspergillus fumigatusMannansFungal ProteinsGalactoseMannosyltransferasesFungal ProteinsgalactomannanGalactoseMannansMannosyltransferasesAspergillus fumigatuscell wallgalactofuranosegalactomannanglycosyltransferasemannosemannosyltransferase

Identifiers

PMID36445154
PMCPMC9769593
OpenAlexW4310457318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.